DRH Shorts Retreat as Analysts Lift Targets

Analyst opinion has been drifting constructively higher for months, though the pace of upgrades has slowed. The clearest recent move came from Truist Securities in September, where the target was lifted to $15 from $12 while keeping a Buy rating, making it the most optimistic call on the register. Barclays and Evercore both raised targets to $14 in August, each keeping neutral-equivalent ratings. Morgan Stanley moved to $11 that same month. The mean target across the group is $13.96, a roughly 13% premium to the current price. The pattern is consistent: firms are marking targets higher but few are turning outright bullish, with the majority clustered in hold or equal-weight territory. EPS surprise ranks in the 92nd percentile of the universe, and the 90-day EPS momentum score sits at 82, which tells you estimates have been moving in the right direction. The bull case rests on the portfolio repositioning into urban and destination markets and a claimed 41.6% discount to replacement cost. The bear case is more macro: lodging is cyclical, and some analysts have already flagged that second-half estimates have been trimmed.

Institutional ownership is concentrated at the top. BlackRock holds 19.1% of shares, adding roughly 1.45 million shares in the period through September 30. Vanguard entities collectively account for another 17% or so across several reported vehicles. These are passive-weight moves rather than conviction calls, but the net direction has been additive. On the 13D/G register, no activist has emerged. The Vanguard Group entity that once held 16.4% of the class filed in March 2026 showing zero shares owned, a notable reorganisation of how the Vanguard complex reports its stake rather than an outright exit, given that other Vanguard vehicles still show substantial holdings. Stakes here are as last disclosed and holders dropping below 5% may exit without a further filing.

Insider activity over the past 90 days has been a net negative on paper. The 90-day net value runs to roughly -$445,000, reflecting two director open-market sales in May and June totalling 40,000 shares. There was also a tiny open-market purchase by director Stephanie Lepori in July, worth about $1,346, which adds symbolic rather than financial weight. None of the recent trades were made under a 10b5-1 plan.

The last two earnings prints are worth keeping in mind. The Q2 report in early August produced a 5.5% drop on the day and a further 7.3% over the subsequent five sessions, the worst post-earnings reaction in the recent history. The print before that, in late July, produced a 3.6% gain on the day but gave back nearly 3% over the following week. With the November 3 date now less than a month away, and short interest still running near 7% of the float despite the recent pullback, the direction of travel into that print is what to watch.